Drug profile · INN
velmanase alfa-tycv
LAMZEDE
velmanase alfa-tycv (LAMZEDE) is a high mannose oligosaccharides hydrolytic enzyme. Current US regulatory status: approved.
Drug details — velmanase alfa-tycv
- US status
- approved
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
velmanase alfa-tycv (LAMZEDE) is a high mannose oligosaccharides hydrolytic enzyme. Current US regulatory status: approved.
Key facts
Mechanism of action
High mannose oligosaccharides hydrolytic enzyme
Primary target: High mannose oligosaccharides
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is velmanase alfa-tycv?
velmanase alfa-tycv (LAMZEDE) is a high mannose oligosaccharides hydrolytic enzyme. Current US regulatory status: approved.
What is the brand name for velmanase alfa-tycv?
LAMZEDE is a marketed brand name for velmanase alfa-tycv. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of velmanase alfa-tycv?
velmanase alfa-tycv has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.